Technology Collaboration with Eli Lilly Makes Quintiles a Top IT Innovator
RESEARCH TRIANGLE PARK, N.C - Thursday, September 13th 2012 [ME NewsWire]
(BUSINESS
WIRE)-- Quintiles ranks 6th in this year’s InformationWeek 500, a list
of the top technology innovators in the United States. The annual list
was revealed last night (September 11th) at an awards ceremony in Dana
Point, CA.
InformationWeek identifies and honors the nation's
most innovative users of information technology with its annual 500
listing, and also tracks the technology, strategies, investments and
administrative practices of America’s best-known companies. The listing
spotlights the power of innovation in information technology, rather
than simply identifying the biggest IT spenders.
The driving
factor behind this year’s InformationWeek 500 ranking was Quintiles’
collaboration with Eli Lilly on an IT-enabled project to re-engineer the
way clinical trials are planned and designed. The ultimate goal of this
collaboration was to develop an integrated approach that eliminates
costly inefficiencies and uses “big data” to drive better drug
development decisions.
Jeff Kasher, vice president, global
clinical development, Eli Lilly, says the collaboration with Quintiles
has yielded a solution which has positively impacted Lilly’s ability to
conduct clinical trials. “To maximize success, full blown disruptive
change was encouraged because we knew incremental change wouldn’t cut
it. I can’t imagine a partner other than Quintiles who could have made
this a reality.”
Quintiles Chief Information Officer Richard
Thomas says his team is very proud to be recognized as one of the
leading technology innovators across all industries. “It is truly a team
effort at Quintiles, and in a world without borders, this award
highlights that we have been able to create something very special in
collaboration with one of our key customers, which will have a profound
effect on clinical research going forward.
“Looking ahead, the
healthcare industry we serve has many formidable problems to solve,”
Thomas continued. “Receiving this award adds to our momentum,
reinforcing the critical and ever more urgent nature of the work we
carry out at Quintiles.”
“The InformationWeek 500 has recognized
the most innovative users of business technology for 24 years, and this
year’s innovations were particularly impressive,” said InformationWeek
Editor in Chief Rob Preston. “What the editors looked for are
unconventional approaches—new technologies, new models, new ways of
grabbing business opportunities and solving complex business problems
with IT.”
Additional details on the InformationWeek 500 can be found online at http://www.informationweek.com/1343.
About InformationWeek Business Technology Network
The
InformationWeek Business Technology Network provides IT executives with
unique analysis and tools that parallel their work flow—from defining
and framing objectives through to the evaluation and recommendation of
solutions. Anchored by InformationWeek, the multimedia powerhouse that
looks across the enterprise, the network scales across the most critical
technology categories with online properties like DarkReading.com
(security), NetworkComputing.com (networking and communications) and
PlugintotheCloud.com (cloud computing).
About Quintiles
Quintiles
is the only fully integrated biopharmaceutical services company
offering clinical, commercial, consulting and capital solutions
worldwide. Our network of more than 25,000 professionals in 60 countries
has an eye on the future while delivering results today with an
unwavering commitment to patients, safety and ethics. Quintiles helps
biopharmaceutical companies develop and commercialize products to
improve and lengthen patients’ lives while demonstrating value to
stakeholders. Visit www.quintiles.com for more information and
www.quintiles.com/news for additional company news.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Phil Bridges, + 1-919-998-1653
Media Relations
phil.bridges@quintiles.com
mobile: +1-919-457-6347
Greg Connors, +1-919-998-2000
Investor Relations
invest@quintiles.com

No comments:
Post a Comment